Bristol Myers Squibb at SCOPE 2027
Mar 1–4, 2027 Orlando, FL ~5k attendees Website
Bristol Myers Squibb brings 15 presentations to SCOPE 2027 in Orlando. Its sessions center on AI in study design, budgeting and site feasibility, and on tighter biospecimen oversight. Concrete topics include touchless processing of serious adverse events, AI-enabled study budgeting and preventing sample overcollection with protocol-guided workflows.
| Organization | SCOPE 2027 Attendance |
|---|---|
Bristol Myers Squibb Princeton, NJ | |
Global pharmaceutical company with medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience. | Talk Tue Mar 2 11:30am–11:55am Talk Tue Mar 2 3:30pm–3:55pm Talk Tue Mar 2 3:30pm–3:55pm Talk Tue Mar 2 3:55pm–4:20pm Panel Tue Mar 2 4:45pm–5:10pm Talk Tue Mar 2 4:45pm–5:10pm Talk Wed Mar 3 9:00am–9:20am Talk Wed Mar 3 9:15am–9:35am Talk Wed Mar 3 9:25am–9:50am Panel Wed Mar 3 9:25am–9:50am Panel Wed Mar 3 11:40am–12:05pm Talk Wed Mar 3 11:40am–12:05pm Talk Wed Mar 3 12:05pm–12:30pm Talk Wed Mar 3 2:35pm–3:00pm Panel Thu Mar 4 8:35am–9:00am Shared Challenges, Shared Solutions: Advancing Biospecimen Management across the Clinical Trial Ecosystem Biospecimen strategy and operations |
Instantly find 20 buyers from Bristol Myers Squibb
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by SCOPE Summit or its organizers. Submit a correction